CYTO(CYTO)
CYTO
No analyst ratings available
No analyst price targets available for CYTO
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E |
|---|---|
| Revenue Avg | $6M |
| Low | $6M |
| High | $6M |
| EBITDA Avg | $408,483 |
| Low | $408,483 |
| High | $408,483 |
| EBIT Avg | $-410,672 |
| Low | $-410,672 |
| High | $-410,672 |
| Net Income Avg | $-707,142 |
| Low | $-707,142 |
| High | $-707,142 |
| EPS Avg | $-1.44 |
| Low | $-1.44 |
| High | $-1.44 |
| Analysts (Rev / EPS) | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $9,572 | $8,395 | $7,362 | $6,456 |
| Low | $9,572 | $8,395 | $7,362 | $6,456 |
| High | $9,572 | $8,395 | $7,362 | $6,456 |
| EBITDA Avg | $2M | $2M | $1M | $1M |
| Low | $2M | $2M | $1M | $1M |
| High | $2M | $2M | $1M | $1M |
| EBIT Avg | $103,962 | $97,882 | $107,572 | $102,726 |
| Low | $103,962 | $97,882 | $107,572 | $102,726 |
| High | $103,962 | $97,882 | $107,572 | $102,726 |
| Net Income Avg | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| Low | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| High | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| EPS Avg | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| Low | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| High | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions
